Free Trial

Avantor (AVTR) Competitors

Avantor logo
$13.51 -0.37 (-2.67%)
Closing price 07/7/2025 03:59 PM Eastern
Extended Trading
$13.46 -0.05 (-0.37%)
As of 07/7/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AVTR vs. DHR, IQV, TMO, KEYS, VLTO, FTV, TER, RVTY, NVMI, and BIO.B

Should you be buying Avantor stock or one of its competitors? The main competitors of Avantor include Danaher (DHR), IQVIA (IQV), Thermo Fisher Scientific (TMO), Keysight Technologies (KEYS), Veralto (VLTO), Fortive (FTV), Teradyne (TER), Revvity (RVTY), Nova (NVMI), and Bio-Rad Laboratories (BIO.B).

Avantor vs. Its Competitors

Danaher (NYSE:DHR) and Avantor (NYSE:AVTR) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Danaher has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Comparatively, Avantor has a beta of 1.05, meaning that its stock price is 5% more volatile than the S&P 500.

Danaher currently has a consensus price target of $248.61, suggesting a potential upside of 24.55%. Avantor has a consensus price target of $18.14, suggesting a potential upside of 34.24%. Given Avantor's higher probable upside, analysts clearly believe Avantor is more favorable than Danaher.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Danaher
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.80
Avantor
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.42

Danaher has higher revenue and earnings than Avantor. Avantor is trading at a lower price-to-earnings ratio than Danaher, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Danaher$23.88B5.98$3.90B$5.1538.76
Avantor$6.78B1.36$711.50M$1.0412.99

Danaher has a net margin of 15.81% compared to Avantor's net margin of 10.70%. Avantor's return on equity of 11.93% beat Danaher's return on equity.

Company Net Margins Return on Equity Return on Assets
Danaher15.81% 10.80% 6.89%
Avantor 10.70%11.93%5.50%

79.1% of Danaher shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 11.2% of Danaher shares are held by company insiders. Comparatively, 1.2% of Avantor shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Danaher had 44 more articles in the media than Avantor. MarketBeat recorded 52 mentions for Danaher and 8 mentions for Avantor. Avantor's average media sentiment score of 1.74 beat Danaher's score of 1.61 indicating that Avantor is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Danaher
48 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Avantor
8 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

Danaher beats Avantor on 11 of the 16 factors compared between the two stocks.

Get Avantor News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVTR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVTR vs. The Competition

MetricAvantorMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$9.46B$7.23B$5.52B$20.71B
Dividend YieldN/A2.78%5.24%3.72%
P/E Ratio12.9926.9227.2627.80
Price / Sales1.3631.99381.2547.18
Price / Cash8.6320.3926.2118.22
Price / Book1.546.687.944.59
Net Income$711.50M$230.16M$3.17B$982.91M
7 Day Performance-2.88%-0.71%1.80%0.65%
1 Month Performance3.33%0.36%1.28%4.26%
1 Year Performance-35.48%41.11%33.57%13.93%

Avantor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVTR
Avantor
4.9784 of 5 stars
$13.51
-2.7%
$18.14
+34.2%
-35.8%$9.46B$6.78B12.9913,500Positive News
DHR
Danaher
4.8568 of 5 stars
$197.40
-0.7%
$248.61
+25.9%
-16.6%$141.27B$23.82B38.3363,000Positive News
IQV
IQVIA
4.875 of 5 stars
$157.69
+0.1%
$226.32
+43.5%
-21.9%$27.28B$15.41B21.4886,000
TMO
Thermo Fisher Scientific
4.9931 of 5 stars
$405.83
-0.6%
$604.05
+48.8%
-22.5%$153.20B$42.88B23.80125,000Positive News
KEYS
Keysight Technologies
4.1645 of 5 stars
$164.05
-0.2%
$183.00
+11.6%
+18.3%$28.23B$5.11B38.5115,000Positive News
VLTO
Veralto
3.1073 of 5 stars
$101.03
0.0%
$110.09
+9.0%
+7.4%$25.04B$5.28B28.8717,000Positive News
FTV
Fortive
4.9183 of 5 stars
$52.20
-27.1%
$82.62
+58.3%
-26.8%$17.74B$6.18B22.8918,000Analyst Upgrade
High Trading Volume
TER
Teradyne
4.9499 of 5 stars
$89.92
-0.5%
$114.33
+27.2%
-40.1%$14.42B$2.82B25.406,500Options Volume
RVTY
Revvity
4.0685 of 5 stars
$96.94
-0.9%
$123.64
+27.5%
-4.7%$11.43B$2.76B41.2511,000Positive News
NVMI
Nova
1.6277 of 5 stars
$275.20
+2.8%
$282.50
+2.7%
+20.1%$8.09B$672.40M41.574,149
BIO.B
Bio-Rad Laboratories
N/A$250.08
flat
N/A-11.8%$6.80B$2.57B-3.288,200

Related Companies and Tools


This page (NYSE:AVTR) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners